Skip to main content

Advertisement

Table 1 Neurophysiological and Magnetic Resonance Spectroscopy findings at baseline and follow-up visits

From: Cerebellar ataxia and sensory ganglionopathy associated with light-chain myeloma

Neurological dysfunction in coeliac disease and Neurological dysfunction in coeliac disease and Neurological dysfunction in coeliac disease and Neurological dysfunction in coeliac disease and Neurological dysfunction in coeliac disease and Neurological dysfunction in coeliac disease and Neurological dysfunction in coeliac disease and Neurological dysfunction in coeliac disease and Neurological dysfunction in coeliac disease and Neurological dysfunction in coeliac disease and Neurological dysfunction in coeliac disease and Neurological dysfunction in coeliac disease and Neurological dysfunction in coeliac disease and Neurological dysfunction in coeliac disease and
Baseline 11.7 8.8 6.3 X 0.8 0.8 2.9 0.7/0.7 10.6/16.3 60.5/55.3 60.7/55.5 0.95 1.04
F/U at 30 m 10.4 X 4.4 11.1 NR 0.5 NR NR X X X 0.83 1.17
F/U at 42 m 10.7 6.6 3.5 11.1 NR NR NR NR X X X 0.80 0.95
F/U at 54 m X X X X X X X X X X X 0.79 0.80
  1. CMAP; compound muscle action potential, SNAP; sensory nerve action potential, L; Left, R; Right, NR; no response, X; not done
  2. Median and ulnar studies - orthodromic, radial, peroneal and sural - antidromic
  3. cR2 = contralateral R2; iR2 = ipsilateral R2